Be a Survivor

Reflecting the combined wisdom of leading medical experts, this book includes clear explanations, color graphics, lists of questions to ask your healthcare professionals, and candid testimonials by patients who have "been there before.

Be a Survivor

Reflecting the combined wisdom of leading medical experts, this book includes clear explanations, color graphics, lists of questions to ask your healthcare professionals, and candid testimonials by patients who have "been there before." This Book Will Help You Regain the feeling of control Assemble the best team of experts Learn how to communicate with your doctors Improve your chances of successful treatment Make informed decisions that are best for you Cope with side effects of treatment Consider appropriate complementary therapies Communicate effectively with your spouse Book jacket.

Lung Cancer

However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.

Lung Cancer

Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.

Controversies in the Treatment of Lung Cancer

Under the auspices of the 12th International Symposium on Special Aspects in Radiotherapy 2008 in Berlin, acknowledged experts presented their perspectives on small and non-small cell lung cancer, reflecting the latest standards and ...

Controversies in the Treatment of Lung Cancer

Under the auspices of the 12th International Symposium on Special Aspects in Radiotherapy 2008 in Berlin, acknowledged experts presented their perspectives on small and non-small cell lung cancer, reflecting the latest standards and engaging in controversies in the diagnosis and treatment of this disease.In the first part of this volume, aspects of the diagnostic workup are highlighted from the histopathologist's point of view, followed by presentations concerning the value of PET-CT and whole-body MRI in the staging of lung cancer. The use and current methods in bronchoscopy, endoscopic ultrasound, video-endoscopy and mediastinoscopy are discussed in detail. The second section presents surgical and radio-oncological treatment concepts for stage I/II non-small cell lung cancer including stereotactic radiotherapy. The third section outlines the curative options for stage III NSCLC: extended surgical approaches , definitive radiochemotherapy and current concepts in adjuvant therapies. Emphasis is also placed on altered fractionation schemes in radiotherapy. Section 4 is dedicated to palliative procedures and the last section gives an in-depth presentation of small cell lung cancer.This book provides an excellent overview of up-to-date standards and future strategies in lung cancer treatment. It will be of great value to surgeons, radiation oncologists, pulmonary specialists and other clinicians interested in this disease.

Targeted Therapies in Lung Cancer Management Strategies for Nurses and Practitioners

This book aims to educate nurses and advanced practice providers (APP’s) about known mutations, availability of targeted therapy and the management of patients with non-small cell lung cancer (NSCLC).

Targeted Therapies in Lung Cancer  Management Strategies for Nurses and Practitioners

This book aims to educate nurses and advanced practice providers (APP’s) about known mutations, availability of targeted therapy and the management of patients with non-small cell lung cancer (NSCLC). It will educate nurses and practitioners about the scope of therapy to assure safe and effective lung cancer treatment. In this era of personalized medicine, nurses and APP’s are responsible for guiding patients from diagnosis through treatment. This starts with the identification of patients that can benefit from these therapies, the key role of biopsy acquisition (ie. what to test, when and how often) and treatment selection based on the mutation identified. Readers will learn about the mechanisms of action, administration, potential adverse side effects and unique management strategies for these targeted agents. Lung cancer continues to be the leading cause of cancer death in the United States and worldwide. Recent advances in the identification of specific oncogenic mutations that drive cancer development, growth and metastasis have led to major paradigm shifts in lung cancer treatment. Sophisticated methods are required to identify specific mutations at the time of diagnosis. This book explains how molecularly targeted therapies have been developed that target these drivers. To date, several tyrosine kinase inhibitors have been approved to target the epidermal growth factor receptor (EGFR), EML4-ALK ,ROS1 and BRAF. Most recently, immune checkpoint inhibitors have been approved with some indication that efficacy may be enhanced for patients who overexpress PD-L1. While some driver mutations have been identified, there is ongoing investigation into additional mutations. In the case of driver mutations, lung cancers will develop resistance to therapy. This book provides nurses and APP’s with the mechanisms of resistance that have been identified such as T790 mutation and many others in the EGFR mutation, and shows how the next level of drug development is focused on identifying mechanisms of resistance and development of new agents that overcome these mutations. With this book in hand, nurses and practitioners will be able to navigate patients through this ever expanding field of lung cancer treatment.

You Can Beat Lung Cancer

Significantly increase your chances of long-term lung cancer survival by using holistic Alternative/Integrative interventions by physicians/ health practitioners.

You Can Beat Lung Cancer

Significantly increase your chances of long-term lung cancer survival by using holistic Alternative/Integrative interventions by physicians/ health practitioners.

Living with a Diagnosis of Lung Cancer

Here are some suggestions for ways you can live well and take positive steps to deal with your diagnosis and treatment.Treatment OptionsThere are more lung cancer treatments today than ever before, including surgery, radiation therapy, ...

Living with a Diagnosis of Lung Cancer

"Living With a Diagnosis of Lung Cancer" is an easy-to-understand booklet written to help lung cancer patients understand their diagnosis and their options as they face the disease.Lung cancer claims more lives than breast, prostate, and colon cancers combined. In fact, over 288,000 people are diagnosed each year in the U.S. People with lung cancer often are told, "Get your affairs in order." But, there is hope for those diagnosed with lung cancer. Thanks to research advances, there are options available to patients diagnosed regardless of the stage of the disease. Much progress is being made with new treatments being developed and tested each day. This valued resource will help you know what questions to ask of your medical team and can help you understand your treatments options in your journey as a patient or caregiver.If you or someone you love is facing a lung cancer diagnosis, "Living with a Diagnosis of Lung Cancer" will help you understand important topics such as: What is Lung Cancer?Understand the basics about how lung cancer forms and spreads, so you can make informed decisions about your treatment and care.Types of Lung CancerDetermining whether you were diagnosed with small-cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC) will influence your treatment options. StagingAfter your lung cancer is diagnosed, your doctors will determine the stage of the disease to understand the location and size of tumors, helping them decide what treatments can be offered. Dealing with a DiagnosisThere isn't one best or easiest way to live with a diagnosis of lung cancer. Here are some suggestions for ways you can live well and take positive steps to deal with your diagnosis and treatment.Treatment OptionsThere are more lung cancer treatments today than ever before, including surgery, radiation therapy, chemotherapy "targeted therapies," and new drugs being tested in clinical trials are also available to many patients. Your Cancer Care TeamIt's important that you feel comfortable talking to the doctors, nurses and specialists who make up your care team. Remember, you have the right to ask questions, discuss treatment options, and openly express your concerns, emotions and wishes. Clinical TrialsClinical trials are medical research studies that offer many patients the most cutting-edge treatment and care available. When you are diagnosed with lung cancer, or if your lung cancer recurs or progresses, you and your doctor should discuss whether a clinical trial is a good treatment option for you. Molecular Tumor TestingSome lung cancer treatments are called "targeted therapies" because they are designed to target specific tumor characteristics. Molecular tumor testing can let you and your doctor know if you have a tumor with one of these characteristics so you can make well-informed decisions about your treatment. Managing Symptoms & Side EffectsYour treatment team is expert at helping you manage the symptoms of your cancer and side effects of your treatments. Understanding some common symptoms will prepare you for dealing with them if they occur. Financial AssistanceFind the help you need to pay for treatment, co-pays, costs of living and legal expenses associated with a lung cancer diagnosis. Patient SupportGet in touch with communities of support that can help you navigate your journey with lung cancer.Other Cancer OrganizationsOur partners can provide help to patients and families seeking further support and information.Free to Breathe is a partnership of lung cancer survivors, advocates, researchers, healthcare professionals and industry leaders united in the belief that every person with lung cancer deserves a cure. This information, and other resources, are available on our website: www.FreetoBreathe.org

Lung Cancer

Dr. Scott also surveys tests for early detection of lung cancer, talks about the importance of cancer staging, examines alternative treatments, and offers advice on coping with emotions such as "smoker's guilt."

Lung Cancer

What is my prognosis? What are my treatment options? Which therapies would be the most effective for my stage of lung cancer? These and other frequently asked questions are addressed in this crucial reference designed to help patients educate themselves and obtain the best possible treatments. The completely revised second edition has been updated to include a discussion of the movement towards customized chemotherapy; treatment options for early-stage lung cancer including minimally invasive surgery; and the most promising treatments, among them multimodality therapy—a combination of surgery, chemotherapy, and radiation. Dr. Scott also surveys tests for early detection of lung cancer, talks about the importance of cancer staging, examines alternative treatments, and offers advice on coping with emotions such as "smoker's guilt."

Lung Cancer Treatment

In this book, the authors present topical research in the study of lung cancer treatments including epidermal growth factor tyrosine kinase inhibitors, in the management of advanced stage non-small cell lung cancer; lung cancer ...

Lung Cancer Treatment

Lung cancer is one of the leading causes of death worldwide with the majority of patients suffering from advanced unresectable or metastatic non-small cell lung cancer. Despite the advances in palliative chemotherapy, the survival rate for patients with this advanced disease treated with chemotherapy remains poor. In this new book, the authors present topical research in the study of lung cancer treatments including epidermal growth factor tyrosine kinase inhibitors, in the management of advanced stage non-small cell lung cancer; lung cancer brachytherapy; volumetric modulated arc therapy and future individualized therapy for lung cancer in post-genomic era.

Lung Cancer

This book comprehensively reviews the evidence that has driven personalized medicine, based on a variety of multidisciplinary perspectives by international lung cancer experts.

Lung Cancer

Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, radiotherapy, and image-guided ablation have contributed to improving the effectiveness and tolerability of potentially curative treatments in early-stage, locally advanced, and oligometastatic/oligoprogressive disease. Chemotherapy, targeted therapy, immunotherapy, and palliative local therapy options have expanded rapidly, with new regimens showing improved outcomes even for those with widely metastatic disease. This book comprehensively reviews the evidence that has driven personalized medicine, based on a variety of multidisciplinary perspectives by international lung cancer experts.

Lung Cancer

Over 50 illustrations and 40 tables round out the text. This thorough, practical volume is the essential clinical guide for oncologists, surgeons, and all physicians involved in the care of patients with lung cancer.

Lung Cancer

Lung cancer remains the leading cause of cancer-related death in men, and in women, it has surpassed even breast cancer. According to the American Cancer Society, in 2001, there will be about 169,500 new cases of lung cancer in the United States: 90,700 among men and 78,800 among women. Lung Cancer is the second installment in the M. D. Anderson Cancer Care Series, featuring the current standard approach to lung cancer care from the experts at M. D. Anderson Cancer Center. Designed for the practicing oncologist, this clinical guidebook allows for quick, authoritative access to the latest and best multimodality therapies. Topics covered in this volume include the clinical examination of patients with suspected lung cancer, thoracic imaging techniques for non-small cell and small cell lung cancer, pathology of lung cancer, treatment and management of non-small and small-cell lung cancer, including the role of guidelines and clinical pathways, molecular events in lung cancer and implications for prevention and therapy, palliation, and much more. Each of the 15 chapters ends with an up-to-date list of suggested readings, as well as "key practice points" highlighting the most important principles and practices of each chapter for at-a-glance reference. Over 50 illustrations and 40 tables round out the text. This thorough, practical volume is the essential clinical guide for oncologists, surgeons, and all physicians involved in the care of patients with lung cancer.

Lung Cancer PART II An Issue of Clinics in Chest Medicine

Topics discussed in this issue include but are not limited to: Lung Cancer TNM Staging: The 8th Edition; New Surgical Approaches in the Treatment of NSCLC; Alternatives to Surgery for Early Stage Non-Small Cell Lung Cancer: Stereotactic ...

Lung Cancer PART II  An Issue of Clinics in Chest Medicine

This issue of Clinics in Chest Medicine, guest-edited by Dr. M. Patricia Rivera, is the second of two issues focused on Lung Cancer. Topics discussed in this issue include but are not limited to: Lung Cancer TNM Staging: The 8th Edition; New Surgical Approaches in the Treatment of NSCLC; Alternatives to Surgery for Early Stage Non-Small Cell Lung Cancer: Stereotactic Radiotherapy; Alternatives to Surgery for Early Stage Non-Small Cell Lung Cancer: Thermal Ablation; Advances in the Treatment of Stage III NSCLC; Advances in Treatment of NSCLC: Targeted Therapy; Advances in the Treatment of NSCLC: Immunotherapy; Treatment of Oligometastatic Disease in NSCLC; Management of Malignant Pleural Effusions; Advances in the Treatment of Small Cell Lung Cancer; Palliative Care and the Role of the Primary Care Physician in Lung Cancer Care; Pulmonary Complications of Immunotherapy; and Pulmonary Complications of Chemotherapy and Radiation Therapy.

100 Questions Answers about Lung Cancer

Guides patients and their families through diagnosis, treatment, and survivorship of lung cancer.

100 Questions   Answers about Lung Cancer

Guides patients and their families through diagnosis, treatment, and survivorship of lung cancer.

Lung Cancer

This book provides essential information on Lung Cancer, but also serves as a historical survey, by providing information on the controversies surrounding its causes, and first-person narratives by people coping with Lung Cancer.

Lung Cancer

According to the Mayo Clinic, Lung Cancer claims more lives each year than colon, prostate, ovarian, and breast cancers combined. This book provides essential information on Lung Cancer, but also serves as a historical survey, by providing information on the controversies surrounding its causes, and first-person narratives by people coping with Lung Cancer. Patients, family members, or caregivers explain the condition from their own experience. The symptoms, causes, treatments, and potential cures are explained in detail. Essential to anyone trying to learn about diseases and conditions, the alternative treatments are explored. Student researchers and readers will find this book easily accessible through its careful and conscientious editing and a thorough introduction to each essay.

Johns Hopkins Patients Guide to Lung Cancer

Johns Hopkins Patients' Guide to Lung Cancer is a concise, easy-to-follow “how to” guide that puts you on the path to wellness by explaining lung cancer treatment from start to finish.

Johns Hopkins Patients  Guide to Lung Cancer

Johns Hopkins Patients' Guide to Lung Cancer is a concise, easy-to-follow “how to” guide that puts you on the path to wellness by explaining lung cancer treatment from start to finish. It guides you through the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and performs the task of putting together your plan of care in layman's terms. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your care and treatment.

Advances in Radiation Oncology in Lung Cancer

This volume is unique in being devoted solely to the radiation oncology of lung cancer, and will be of great value to all who are involved in the diagnosis and treatment of the disease.

Advances in Radiation Oncology in Lung Cancer

Although decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. This volume is unique in being devoted solely to the radiation oncology of lung cancer, and will be of great value to all who are involved in the diagnosis and treatment of the disease. Both non-small cell and small cell lung cancer are considered in detail. Current state-of-the-art treatment strategies and novel approaches that promise further improvements in outcome are explained and evaluated, with the aid of high-quality illustrations. Treatment-related toxicity is discussed, and further individual chapters focus on topics such as quality of life studies, prognostic factors and pitfalls in the design and analysis of clinical trials.

Advances in Radiation Oncology in Lung Cancer

This is the second, completely updated edition of a comprehensive book in which many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research ...

Advances in Radiation Oncology in Lung Cancer

This is the second, completely updated edition of a comprehensive book in which many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research findings. The first three sections cover the basic science of lung cancer, clinical investigations, including histology and staging, and a wide range of fundamental treatment considerations. Current treatment strategies for small cell and non-small cell lung cancer are then explained and evaluated in detail, with due attention to novel approaches that promise further improvements in outcome. The various types of treatment-related toxicity are discussed, and quality of life studies and prognostic factors are also considered. After evaluating the latest technological and biological advances, including IMRT, IMAT, cyber knife treatment, and tomotherapy, the book concludes by thorough consideration of specific aspects of clinical research in lung cancer.

Lung Cancer An Issue of Surgical Oncology Clinics of North America E Book

This issue of Surgical Oncology Clinics of North America, guest edited by Dr. Mark Krasna, is devoted to Lung Cancer.

Lung Cancer  An Issue of Surgical Oncology Clinics of North America  E Book

This issue of Surgical Oncology Clinics of North America, guest edited by Dr. Mark Krasna, is devoted to Lung Cancer. Dr. Krasna has assembled expert authors to review the following topics: Epidemiology for Lung Cancer; Screening for Lung Cancer; Pathology for Lung Cancer; Treatment of Patients with Oligometastatic Disease for NSCLC; SBRT/Ablative Therapies for NSCLC; Mediastinal Staging for Lung Cancer; VATS Lobectomy for NSCLC; Robotic Lung Resection for NSCLC; Pneumonectomy for NSCLC; Bronchoscopy-Diagnostic and Therapeutic for NSCLC; Neoadjuvant Therapy for Lung Cancer; Molecular/Targeted Therapy for Lung Cancer; Adjuvant Therapy for Stage 1and 2 NSCLC, and more!

The Treatment of Metastatic Non small Cell Lung Cancer NSCLC in New Era of Personalised Medicine

Lung cancer is the leading cause of cancer related mortality in Canada and USA. Majority of the patients present in advanced stage of the disease and of these only about 2% will be alive at 5 years.

The Treatment of Metastatic Non small Cell Lung Cancer  NSCLC  in New Era of Personalised Medicine

Lung cancer is the leading cause of cancer related mortality in Canada and USA. Majority of the patients present in advanced stage of the disease and of these only about 2% will be alive at 5 years. NSCLC is the most common form of lung cancer, accounting for approximately 87% of cases. Systemic chemotherapies have been used to treat metastatic NSCLC for decades, but the improvements of outcomes have reached a plateau. Recent advances in understanding signalling pathways for malignant cells, their interconections,the importance of various receptors and biomarkers and the interplay between various oncogenes have led to the development of targeted treatments that are improving both efficacy and safety of the treatments. Knowledge about the advantages of treatments with the targeted agents in metastatic NSCLC is growing rapidly. Combining various targeted agents or sequencing them properly will be important in the era of personalised medicine and overcoming development of the resistence to various targeted agents will be challenging. The importance of a team work,from the diagnosis through various treatments, to supportive care, from the interventional radiologists, pneumologists or surgeons, who have to obtain a satisfactory tumor tissue specimen, to pathologists, radiation and medical oncologists, to supportive care specialists, will be described in our publications. We will cover completely present and future approaches to personalised medicine in this rapidly evolving field of metastatic NSCLC.

Diagnosis and Treatment of Lung Cancer

Access comprehensive, multidisciplinary guidance on the diagnosis and treatment of lung cancer!

Diagnosis and Treatment of Lung Cancer

Access comprehensive, multidisciplinary guidance on the diagnosis and treatment of lung cancer! This new resource addresses the full range of clinical issues in diagnosis, staging, and treatment, as well as the latest scientific data and evidence-based guidelines. A user-friendly organization provides quick reference to data summaries, as well as more comprehensive and detailed information for readers who wish to explore topics in depth. Features contributions by authors from many different disciplines, to ensure a balanced approach. Addresses the clinical issues seen in practice, with the inclusion of basic science research topics that are likely to be put into clinical practice soon. Integrates evidence-based medicine throughout. Assesses the strength of all available dataenabling readers to weigh different arguments and make decisions based on medical issues, values, and the availability and efficacy of interventionsusing a data rating system. Addresses difficult, but clinically relevant issues for which limited data is available. Enables readers to quickly reference findings and data in data summary statements and summary tables.